Business Context and Reporting Period
Company: Nephros, Inc.
Filing Type: Form 8-K (Current Report)
Date: June 17, 2005
Event: Announcement of regulatory approval for a medical device.
Key Financial Metrics
This filing is a Current Report (Form 8-K) regarding a specific corporate event and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity is not provided in this document.
Material Changes
The material change reported is the receipt of 510(k) approval from the United States Food and Drug Administration (FDA) for the company's OLpur(TM) HD190 dialyzer. This approval permits the marketing of the device in the United States.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) detailing the FDA approval but does not include specific forward-looking guidance, financial outlook, or risk factors within the body of this 8-K text.
Unusual Items: None reported beyond the regulatory milestone.
Investor Verification Checklist
- Verify the commercial launch timeline for the OLpur(TM) HD190 dialyzer following FDA approval.
- Review the full text of the press release (Exhibit 99.1) for specific details on the device's capabilities and market positioning.
- Check subsequent filings (10-Q or 10-K) for the financial impact of this product launch on revenue and operating expenses.
- Confirm if the 510(k) approval includes any specific conditions or limitations on the device's use.